Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and the number of locations reduced from 72 to 67, with several sites removed. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision updated to v3.6.0.SummaryDifference0.8%

- Check17 days agoChange DetectedThe page's revision label was updated to v3.5.5, replacing v3.5.4, indicating a new backend build rather than a substantive content change.SummaryDifference0.0%

- Check39 days agoChange DetectedLocation data on the study page were updated, adding corrected postal codes for Hong Kong and Sapporo and adjusting associated dates. This clarifies where the trial is conducted and how to contact the sites.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a site software/version change rather than a change to the trial information displayed.SummaryDifference0.0%

- Check68 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedEnrollment (Actual) updated to 330 on 2026-04-08. The previous value 331 was removed on 2026-03-02.SummaryDifference0.1%

Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.